Tenon Medical Launches Catamaran SE SI Joint Fusion System for Full Market Release

Tenon Medical has launched its Catamaran SE SI Joint Fusion System, expanding its implant portfolio with a smaller implant option for sacroiliac joint fusion procedures. The device features a reduced profile and supports a minimally invasive surgical approach. The company has prepared for full market release with expanded inventories and enhanced commercial leadership following the SiVantage acquisition.

Tenon Medical, Inc. (NASDAQ:TNON) has announced the full commercial launch of its Catamaran SE SI Joint Fusion System, expanding its implant portfolio with a smaller implant option for sacroiliac joint fusion procedures. The device features a reduced profile and supports a minimally invasive surgical approach. The company has prepared for full market release with expanded inventories and enhanced commercial leadership following the SiVantage acquisition.

The Catamaran SE Fixation Device offers physicians greater flexibility when treating patients with smaller SI joint anatomy or revising previously treated joints where available space is limited. Designed for use with a dedicated proprietary instrument set, the Catamaran SE supports a minimally invasive inferior-posterior surgical approach to the SI joint. The instrument set includes a hand drill option for physicians who prefer manual drilling during implant site preparation.

The titanium implant has demonstrated strong clinical performance with over 1,000 devices implanted to date, showing promising early results in the MAINSAIL Clinical Study for achieving successful fusion. The Catamaran SE launch expands Tenon's SI joint fusion portfolio with a smaller implant option, strengthening its market position against competitors.

Tenon Medical's strategic expansion addresses critical market segments, such as patients with smaller SI joint anatomy and revision cases where space is limited. The company's infrastructure investment suggests significant adoption potential. The Catamaran SE maintains the core technical advantages of the original Catamaran technology, placed via a minimally invasive inferior-posterior approach.

Early clinical feedback appears positive, with Dr. John Wrightson highlighting the device's ability to provide immediate SI joint stabilization. The ongoing MAINSAIL Clinical Study indicates Tenon is gathering additional clinical evidence to support adoption.

In the competitive SI joint fusion market, dominated by players like SI-BONE and Globus Medical, Tenon's product expansion strengthens its portfolio with differentiated features such as the proprietary instrument set that includes a hand drill option for physicians preferring manual drilling. This customization could appeal to specific surgeon preferences.

Reference List:
[1] https://www.morningstar.com/news/accesswire/1062324msn/tenonr-medical-announces-the-full-market-launch-of-the-catamaranr-se-si-joint-fusion-system
[2] https://www.stocktitan.net/news/TNON/tenon-r-medical-announces-the-full-market-launch-of-the-catamaran-r-ds00pqzxlu5y.html